Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Access to medicines and treatment
Desperate patients turn to buyers clubs

What do you do when the NHS won’t buy the treatment you need?

Published
25 June 2019
From
The Economist (free registration required)
Retention and linkage to care
Cash Incentives, Peer Support May Not Incentivize HCV Treatment

A randomized trial comparing a cash incentive to peer support for increasing acceptance of treatment for hepatitis C virus (HCV) among persons with HCV/HIV coinfection, including those who use drugs or alcohol, found both methods helpful but that 1 in 4 patients still declined treatment.

Published
10 May 2019
From
MD Magazine
Elimination of hepatitis C
England hits WHO 2020 hepatitis C target three years early

Deaths from liver disease related to serious hepatitis C (HCV) fell by more than 16% between 2015 and 2017, according to data published by Public Health England (PHE). As a result, England has hit the World Health Organization’s (WHO’s) target to reduce HCV related mortality by 10% by 2020 three years early.

Published
18 April 2019
From
The Pharmaceutical Journal
Hepatitis and HIV
Summary from CROI 2019 for viral Hepatitis, from Jürgen Rockstroh

Although no new drugs for HBV or HCV therapy were presented a whole range of important clinical studies were discussed which all have important clinical implications for daily practice.

Published
09 April 2019
From
NATAP
Hepatitis C treatment
Hepatitis C deaths fall by 16 per cent between 2015 and 2017

Deaths from serious hepatitis C related liver disease fell by 16.1% between 2015 and 2017 according to data from PHE.

Published
09 April 2019
From
Public Health England
Hepatitis C treatment
Armenia gets license to produce drugs for hepatitis C treatment

The Armenian Ministry of Health and the Gilead Science Ireland UC have signed a Memorandum of Understanding, under which Gilead will provide Armenia with a license to produce, pack and import genetic drugs for hepatitis C treatment.

Published
03 April 2019
From
Public Radio of Armenia
Elimination of hepatitis C
San Francisco Study Shows Engagement in HCV Care Aids Elimination

In San Francisco, many transwomen have access to hepatitis C virus (HCV) testing and treatment, which suggests an opportunity for HCV control and elimination, according to a study recently published in the Journal of Viral Hepatitis.

Published
02 April 2019
From
Infectious Disease Advisor
Hepatitis C treatment
Louisiana picks drug company for hepatitis C treatment plan

Gilead Sciences subsidiary Asegua Therapeutics LLC won the contract, selected from three companies that sought to partner with the state. Louisiana will pay a fee to the drug manufacturer for unlimited access to its hepatitis C medication, a generic version of Epclusa, for five years.

Published
27 March 2019
From
San Francisco Chronicle
Hepatitis C treatment
Pilot study finds HCV treatment safe in pregnancy

A small pilot study of hepatitis C treatment in pregnant women found that that the treatment was effective in achieving hepatitis C cure and identified no safety concerns associated with treatment, according to findings presented at CROI.

Published
11 March 2019
From
Healio
Organ transplants
'Patient No. 1' from a Hep C heart transplant study shares his story

By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.

Published
08 March 2019
From
Cardiovascular Business
← First12345...75Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.